The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers

Nature Immunology

Volumn 9, Issue 7, 2008, Pages 785-793

  Ni, Zuyao ^a   Hassan, Mohamed Abou El ^a   Xu, Zhaodong ^a   Yu, Tao ^a   Bremner, Rod ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR; PROTEIN CIITA; PROTEIN P300; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE LOCATION; GENE LOCUS; GENETIC REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CHROMATIN; DNA HELICASES; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REGULATOR; HELA CELLS; HUMANS; INTERFERON TYPE II; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 45549089584     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1619     Document Type: Article

References (53)

1. Wright, K.L. & Ting, J.P. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol. 27, 405-412 (2006).
2. Swanberg, M. et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 37, 486-494 (2005).
3. Holling, T.M., van Eggermond, M.C., Jager, M.J. & van den Elsen, P.J. Epigenetic silencing of MHC2TA transcription in cancer. Biochem. Pharmacol. 72, 1570-1576 (2006).
4. Dunn, G.P., Koebel, C.M. & Schreiber, R.D. Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6, 836-848 (2006).
5. Maher, S.G., Romero-Weaver, A.L., Scarzello, A.J. & Gamero, A.M. Interferon: Cellular executioner or white knight? Curr. Med. Chem. 14, 1279-1289 (2007).
6. Ullrich, E. et al. Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells. Cancer Res. 67 851-853 (2007).
7. Muhlethaler-Mottet, A., Di Berardino, W., Otten, L.A. & Mach, B. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity 8, 157-166 (1998).
8. Morris, A.C., Beresford, G.W., Mooney, M.R. & Boss, J.M. Kinetics of a gamma interferon response: Expression and assembly of CIITA promoter IV and inhibition by methylation. Mol. Cell. Biol. 22, 4781-4791 (2002).
9. Ni, Z. et al. Apical role for BRG1 in cytokine-induced promoter assembly. Proc. Natl. Acad. Sci. USA 102, 14611-14616 (2005).
10. Muhlethaler-Mottet, A., Otten, L.A., Steimle, V. & Mach, B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16, 2851-2860 (1997).
11. van der Stoep, N. et al. Constitutive and IFNγ-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region. Mol. Immunol. 44, 2036-2049 (2007).
12. Piskurich, J.F., Linhoff, M.W., Wang, Y. & Ting, J.P. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol. Cell. Biol. 19, 431-440 (1999).
13. Chi, T. A BAF-centred view of the immune system. Nat. Rev. Immunol. 4, 965-977 (2004).
14. Kadam, S. & Emerson, B.M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 11, 377-389 (2003).
15. Muchardt, C. & Yaniv, M. When the SWI/SNF complex remodels...the cell cycle. Oncogene 20, 3067-3075 (2001).
16. Trotter, K.W. & Archer, T.K. Nuclear receptors and chromatin remodeling machinery. Mol. Cell. Endocrinol. 265-266, 162-167 (2007).
17. Agalioti, T., Chen, G. & Thanos, D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111, 381-392 (2002).
18. Salma, N., Xiao, H., Mueller, E, & Imbalzano, A.N. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor γ nuclear hormone receptor. Mol. Cell. Biol. 24, 4651-4663 (2004).
19. Armstrong, J.A., Bieker, J.J. & Emerson, B.M.A. SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 95, 93-104 (1998).
20. Fryer, C.J. & Archer, T.K. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393, 88-91 (1998).
21. Liu, R. et al. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106, 309-318 (2001).
22. Liu, H, Kang, H., Liu, R., Chen, X. & Zhao, K. Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol. Cell. Biol. 22, 6471-6479 (2002).
23. Chi, T.H. et al. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 418, 195-199 (2002).
24. Cai, S., Lee, C.C. & Kohwi-Shigematsu, T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38, 1278-1288 (2006).
25. Im, H. et al. Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc. Natl. Acad. Sci. USA 102, 17065-17070 (2005).
26. O'Neill, D. et al. Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching. Proc. Natl. Acad. Sci. USA 96, 349-354 (1999).
27. Bultman, S.J., Gebuhr, T.C. & Magnuson, T.A. Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in β-globin expression and erythroid development. Genes Dev. 19, 2849-2861 (2005).
28. Kim, S.I., Bultman, S.J., Jing, H., Blobel, G.A. & Bresnick, E.H. Dissecting molecular steps in chromatin domain activation during hematopoietic differentiation. Mol. Cell. Biol. 27, 4551-4565 (2007).
29. Bazett-Jones, D.P., Cote, J., Landel, C.C., Peterson, C.L. & Workman, J.L. The SWI/SNF complex creates loop domains in DNA and polynucleosome arrays and can disrupt DNA-histone contacts within these domains. Mol. Cell. Biol. 19, 1470-1478 (1999).
30. Pattenden, S.G., Klose, R., Karaskov, E. & Bremner, R. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent. EMBO J. 21, 1978-1986 (2002).
31. Huang, M. et al. Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-α-inducible genes. Nat. Cell Biol. 4, 774-781 (2002).
32. Cui, K. et al. The chromatin-remodeling BAF complex mediates cellular antiviral activities by promoter priming. Mol. Cell. Biol. 24, 4476-4486 (2004).
33. Yan, Z. et al. PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev. 19, 1662-1667 (2005).
34. Ni, Z. & Bremner, R. Brahma-related gene 1-dependent STAT3 recruitment at IL-6-inducible genes. J. Immunol. 178, 345-351 (2007).
35. Bernstein, B.E. et al. Genomic maps and comparative analysis of histone modificattions in human and mouse. Cell 120, 169-181 (2005).
36. Heintzman, N.D. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318 (2007).
37. Bernstein, B.E., Messner, A. & Lander, E.S. The mammalian epigenome. Cell 128, 669-681 (2007).
38. Dekker, J., Rippe, K., Dekker, M. & Kleckner, N. Capturing chromosome conformation. Science 295, 1306-1311 (2002).
39. Bultman, S.J. et al. Maternal BRG1 regulates zygotic genome activation in the mouse. Genes Dev. 20, 1744-1754 (2006).
40. Nakamura, T. et al. ALL-1 is a histone methyltransferase that assembles a super-complex of proteins involved in transcriptional regulation. Mol. Cell 10, 1119-1128 (2002).
41. Baiker, A. et al. Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat. Cell Biol. 2, 182-184 (2000).
42. Warming, S., Costantino, N., Court, D.L., Jenkins, N.A. & Copeland, N.G. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33, e36 (2005).
43. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007).
44. Azuara, V. et al. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8, 532-538 (2006).
45. Hartman, S.E. et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev. 19, 2953-2968 (2005).
46. Bhinge, A.A., Kim, J., Euskirchen, G.M., Snyder, M. & Iyer, V.R. Mapping the chromosomal targets of STAT1 by sequence tag analysis of genomic enrichment (STAGE). Genome Res. 17, 910-916 (2007).
47. Robertson, G. et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4, 651-657 (2007).
48. Christova, R. et al. P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNy. J. Cell. Sci. 120, 3262-3270 (2007).
49. Zhang, W. et al. Aldosterone-sensitive repression of ENaCα transcription by a histone H3 lysine-79 methyltransferase. Am. J. Physiol. Cell Physiol. 290, C936-C946 (2006).
50. Steger, D.J. et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008).
51. Tamkun, J.W. et al. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SW12. Cell 68, 561-572 (1992).
52. Pattenden, S. Analysis of chromatin remodeling in an IFN-γ responsive system. Thesis, Univ. Toronto (2003).
53. Reid, G. et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707 (2003).